Literature DB >> 7502531

Medical management of esophageal reflux.

B I Hirschowitz1.   

Abstract

Gastroesophageal reflux of varying severity is a common disorder for which medical attention is sought at all levels, from pharmacists to specialist physicians and surgeons. This brief overview represents my current understanding of reflux, its effects on the esophagus and my personal approach to treatment of these disorders. Of necessity, because the literature is so extensive (a Medline search on reflux from 1966 to 1993 yielded over 1500 papers.), I have relied in places on the extensive review by Marks and Richter [1]. My paper emphasizes the evaluation and treatment of patients with symptomatic reflux, esophagitis and its complications. It describes why it is important to grade the disorders so that the treatment used is appropriate to the severity of the disease. The more severe the disease, the more specific the diagnostic information needed and the more exacting the treatment. Various treatments and outcomes of therapy are discussed, and a role for surgery is defined. The essence of effective medical treatment of esophagitis is to reduce acidity of the refluxate to a level outside the optimum proteolytic pH range of pepsin, i.e. greater than pH 3.5.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7502531      PMCID: PMC2588930     

Source DB:  PubMed          Journal:  Yale J Biol Med        ISSN: 0044-0086


  32 in total

1.  The effects of lansoprazole, 30 or 60 mg daily, on intragastric pH and on endocrine function in healthy volunteers.

Authors:  H G Dammann; A von zur Mühlen; H J Balks; A Damaschke; J Steinhoff; U Hennig; J A Schwarz; W Fuchs
Journal:  Aliment Pharmacol Ther       Date:  1993-04       Impact factor: 8.171

2.  Acid and pepsin secretion in patients with esophagitis refractory to treatment with H2 antagonists.

Authors:  B I Hirschowitz
Journal:  Scand J Gastroenterol       Date:  1992-06       Impact factor: 2.423

3.  Cost and quality effects of alternative treatments for persistent gastroesophageal reflux disease.

Authors:  A L Hillman; B S Bloom; A M Fendrick; J S Schwartz
Journal:  Arch Intern Med       Date:  1992-07

4.  Medical therapy of patients with reflux oesophagitis poorly responsive to H2-receptor antagonist therapy.

Authors:  E C Klinkenberg-Knol; S G Meuwissen
Journal:  Digestion       Date:  1992       Impact factor: 3.216

Review 5.  Acid suppression in the long-term treatment of peptic stricture and Barrett's oesophagus.

Authors:  L Lundell
Journal:  Digestion       Date:  1992       Impact factor: 3.216

Review 6.  Controlled clinical trials of omeprazole in the long-term management of reflux disease.

Authors:  D J Hetzel
Journal:  Digestion       Date:  1992       Impact factor: 3.216

Review 7.  Epidemiology and natural history of gastro-oesophageal reflux disease.

Authors:  S J Spechler
Journal:  Digestion       Date:  1992       Impact factor: 3.216

8.  Appropriate acid suppression for the management of gastro-oesophageal reflux disease.

Authors:  N J Bell; D Burget; C W Howden; J Wilkinson; R H Hunt
Journal:  Digestion       Date:  1992       Impact factor: 3.216

9.  Severe peptic oesophagitis.

Authors:  P L Brunnen; A M Karmody; C D Needham
Journal:  Gut       Date:  1969-10       Impact factor: 23.059

Review 10.  Pathobiology and management of hypergastrinemia and the Zollinger-Ellison syndrome.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1992 Nov-Dec
View more
  2 in total

Review 1.  Management of refractory and complicated reflux esophagitis.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1996 May-Jun

Review 2.  Pepsin and the esophagus.

Authors:  B I Hirschowitz
Journal:  Yale J Biol Med       Date:  1999 Mar-Jun
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.